172 related articles for article (PubMed ID: 23055733)
1. Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer.
da Paz MC; Santos Mde F; Santos CM; da Silva SW; de Souza LB; Lima EC; Silva RC; Lucci CM; Morais PC; Azevedo RB; Lacava ZG
Int J Nanomedicine; 2012; 7():5271-82. PubMed ID: 23055733
[TBL] [Abstract][Full Text] [Related]
2. Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells.
Pereira I; Sousa F; Kennedy P; Sarmento B
Int J Pharm; 2018 Oct; 549(1-2):397-403. PubMed ID: 30110619
[TBL] [Abstract][Full Text] [Related]
3. Photoactive imaging and therapy for colorectal cancer using a CEA-Affimer conjugated Foslip nanoparticle.
Khaled YS; Khot MI; Aiyappa-Maudsley R; Maisey T; Pramanik A; Tiernan J; Lintern N; Al-Enezi E; Shamsuddin SH; Tomlinson D; Coletta L; Millner PA; Hughes TA; Jayne DG
Nanoscale; 2024 Apr; 16(14):7185-7199. PubMed ID: 38506227
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of monoclonal anti-carcinoembryonic antigen (CEA) antibody internalization by electron microscopy, western blotting and radioimmunoassay.
Tsaltas G; Ford CH; Gallant M
Anticancer Res; 1992; 12(6B):2133-42. PubMed ID: 1295459
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect and toxicity of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles in mice bearing breast cancer.
Carneiro ML; Peixoto RC; Joanitti GA; Oliveira RG; Telles LA; Miranda-Vilela AL; Bocca AL; Vianna LM; da Silva IC; de Souza AR; Lacava ZG; Báo SN
J Nanobiotechnology; 2013 Feb; 11():4. PubMed ID: 23414068
[TBL] [Abstract][Full Text] [Related]
6. Targeted killing of colorectal cancer cell lines by a humanised IgG1 monoclonal antibody that binds to membrane-bound carcinoembryonic antigen.
Conaghan P; Ashraf S; Tytherleigh M; Wilding J; Tchilian E; Bicknell D; Mortensen NJ; Bodmer W
Br J Cancer; 2008 Apr; 98(7):1217-25. PubMed ID: 18349843
[TBL] [Abstract][Full Text] [Related]
7. d,l-lysine functionalized Fe
Antal I; Koneracka M; Kubovcikova M; Zavisova V; Khmara I; Lucanska D; Jelenska L; Vidlickova I; Zatovicova M; Pastorekova S; Bugarova N; Micusik M; Omastova M; Kopcansky P
Colloids Surf B Biointerfaces; 2018 Mar; 163():236-245. PubMed ID: 29306846
[TBL] [Abstract][Full Text] [Related]
8. Co-nanoencapsulation of magnetic nanoparticles and selol for breast tumor treatment: in vitro evaluation of cytotoxicity and magnetohyperthermia efficacy.
Estevanato LL; Da Silva JR; Falqueiro AM; Mosiniewicz-Szablewska E; Suchocki P; Tedesco AC; Morais PC; Lacava ZG
Int J Nanomedicine; 2012; 7():5287-99. PubMed ID: 23055734
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of iron oxide magnetic nanoparticles functionalized by nisin.
Gruskiene R; Krivorotova T; Staneviciene R; Ratautas D; Serviene E; Sereikaite J
Colloids Surf B Biointerfaces; 2018 Sep; 169():126-134. PubMed ID: 29758538
[TBL] [Abstract][Full Text] [Related]
10. "Catch-and-Release" Anti-Carcinoembryonic Antigen Monoclonal Antibody Leads to Greater Plasma and Tumor Exposure in a Mouse Model of Colorectal Cancer.
Engler FA; Polli JR; Li T; An B; Otteneder M; Qu J; Balthasar JP
J Pharmacol Exp Ther; 2018 Jul; 366(1):205-219. PubMed ID: 29735609
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells.
Shiozawa M; Chang CH; Huang YC; Chen YC; Chi MS; Hao HC; Chang YC; Takeda S; Chi KH; Wang YS
BMC Immunol; 2018 Aug; 19(1):27. PubMed ID: 30075754
[TBL] [Abstract][Full Text] [Related]
12. In situ synthesis and characterization of magnetic nanoparticles in shells of biodegradable polyelectrolyte microcapsules.
Lyubutin IS; Starchikov SS; Bukreeva TV; Lysenko IA; Sulyanov SN; Korotkov NY; Rumyantseva SS; Marchenko IV; Funtov KO; Vasiliev AL
Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():225-33. PubMed ID: 25491824
[TBL] [Abstract][Full Text] [Related]
13. Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy.
Lorente C; Cabeza L; Clares B; Ortiz R; Halbaut L; Delgado ÁV; Perazzoli G; Prados J; Arias JL; Melguizo C
Colloids Surf B Biointerfaces; 2018 Nov; 171():553-565. PubMed ID: 30096477
[TBL] [Abstract][Full Text] [Related]
14. Magnetic nanoparticles for in vivo use: a critical assessment of their composition.
da Costa GM; Blanco-Andujar C; De Grave E; Pankhurst QA
J Phys Chem B; 2014 Oct; 118(40):11738-46. PubMed ID: 25211599
[TBL] [Abstract][Full Text] [Related]
15. Maghemite nanoparticles protectively coated with poly(ethylene imine) and poly(ethylene oxide)-block-poly(glutamic acid).
Thünemann AF; Schütt D; Kaufner L; Pison U; Möhwald H
Langmuir; 2006 Feb; 22(5):2351-7. PubMed ID: 16489828
[TBL] [Abstract][Full Text] [Related]
16. Raman, EELS and XPS studies of maghemite decorated multi-walled carbon nanotubes.
Zhang W; Stolojan V; Silva SR; Wu CW
Spectrochim Acta A Mol Biomol Spectrosc; 2014; 121():715-8. PubMed ID: 24374884
[TBL] [Abstract][Full Text] [Related]
17. Low toxic maghemite nanoparticles for theranostic applications.
Kuchma EA; Zolotukhin PV; Belanova AA; Soldatov MA; Lastovina TA; Kubrin SP; Nikolsky AV; Mirmikova LI; Soldatov AV
Int J Nanomedicine; 2017; 12():6365-6371. PubMed ID: 28919740
[TBL] [Abstract][Full Text] [Related]
18. Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody.
Stein R; Govindan SV; Hayes M; Griffiths GL; Hansen HJ; Horak ID; Goldenberg DM
Clin Cancer Res; 2005 Apr; 11(7):2727-34. PubMed ID: 15814655
[TBL] [Abstract][Full Text] [Related]
19. Anti-CEA tagged iron nanoparticles for targeting triple-negative breast cancer.
Correa TS; Bocca AL; Figueiredo F; Lima ECO; Almeida Santos MFM; Lacava ZGM; Campos-da-Paz M
Biomed Mater; 2021 Mar; 16(3):. PubMed ID: 33540396
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution and Tumor Targeted Accumulation of Anti-CEA-loaded Iron Nanoparticles.
Correa TS; Lima WG; do Couto Campos AB; Galdino AS; de Oliveira Lima EC; Cardoso VN; Antunes Fernandes SO; Campos-da-Paz M
Curr Pharm Biotechnol; 2024 Feb; ():. PubMed ID: 38321899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
